AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome

Molecular Therapy - Methods and Clinical Development - United States
doi 10.1016/j.omtm.2019.01.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Drosophila Model of Barth Syndrome

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Lentiviral Gene Replacement Therapy of Retinas in a Mouse Model for Usher Syndrome Type 1B

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2007English

AAV9-mediated Gene Transfer of Desmin Ameliorates Cardiomyopathy in Desmin-Deficient Mice

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Cardiac Gene Therapy With Phosphodiesterases PDE2A and PDE4B Ameliorates Cardiac Function in a Mouse Model of Heart Failure Induced by Chronic Isoproterenol Infusion

Biophysical Journal
Biophysics
2017English

AAV9-NPC1 Significantly Ameliorates Purkinje Cell Death and Behavioral Abnormalities in Mouse NPC Disease

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2017English

A Novel Alu-Mediated Xq28 Microdeletion Ablates TAZ and Partially Deletes DNL1L in a Patient With Barth Syndrome

American Journal of Medical Genetics, Part A
Genetics
2009English

Ghrelin Ameliorates Adhesions in a Postsurgical Mouse Model

Journal of Surgical Research
Surgery
2016English

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice

Frontiers in Pharmacology
Pharmacology
2018English

BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson’s Disease

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy